Cite
HARVARD Citation
Zhao, J. et al. (2022). Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism. Bioorganic & medicinal chemistry letters. p. . [Online].